Gilead Sciences, Inc focuses mostly on drugs and treatments including those for hepatitis, HIV and influenza

Commonly known as Gilead Sciences or simply Gilead, the company has traditionally enjoyed thriving stock in 2013-2014. Yet recently in 2018 going into 2019 the stock prices have begun to fall for Gilead Sciences.